Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like S.S.Mundra retires, N.S. Vishwanathan to head RBI supervisory departments July 31, 2017 How HDFC Bank is giving shape to its digital vision May 19, 2017 Milling Tool Steel at a Record 1000cc/min May 8, 2019